What food items can interfere with CYP2C9 (cytochrome P450 2C9) enzyme activity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Food Items That Interfere with CYP2C9 Enzyme Activity

Several food items can significantly inhibit CYP2C9 enzyme activity, potentially increasing the risk of adverse effects with medications metabolized through this pathway, particularly warfarin. 1, 2

Key Food Inhibitors of CYP2C9

Vegetables and Herbs

  • Turmeric/Curcumin: Significantly inhibits CYP2C9 activity (25-75% inhibition) 1
  • Danshen (Chinese herb): Inhibits CYP2C9 and can increase bleeding risk with warfarin 3
  • Garlic: Shows inhibitory effects on CYP2C9, potentially affecting warfarin metabolism 1
  • Ginger: Contains constituents that can inhibit CYP2C9 activity 1
  • Celery, thyme, and green pepper: Contain luteolin which affects drug metabolism through CYP pathways 3

Fruits

  • Grapefruit juice: While primarily known for CYP3A4 inhibition, it can also affect CYP2C9 to a lesser extent 4
  • Cranberry: Can interact with warfarin metabolism, potentially through CYP2C9 inhibition 1

Other Food Items

  • St. John's Wort: Induces CYP2C9, potentially reducing effectiveness of medications metabolized by this pathway 1
  • High-protein diets: May increase CYP450 activity, potentially reducing effectiveness of warfarin 5
  • Thymoquinone (found in Nigella sativa/black cumin): Competitively inhibits CYP2C9 with potential to affect warfarin metabolism 6

Clinical Significance

The inhibition of CYP2C9 is particularly important for patients taking:

  1. Warfarin: S-warfarin, the more potent isomer, is primarily metabolized by CYP2C9 2
  2. NSAIDs: Many are metabolized by CYP2C9, including diclofenac and naproxen 1
  3. Sulfonylureas: Medications like glipizide are CYP2C9 substrates 1

Monitoring Recommendations

  • For patients on warfarin, more frequent INR monitoring is recommended when starting, changing, or stopping foods known to affect CYP2C9 1
  • Patients should maintain consistent dietary habits while on medications with narrow therapeutic indices like warfarin 3
  • Particular caution is needed with dietary supplements containing concentrated forms of CYP2C9 inhibitors (e.g., turmeric supplements) 1

Practical Advice for Patients

  • Avoid sudden large changes in consumption of foods known to affect CYP2C9
  • Inform healthcare providers about all dietary supplements and significant dietary changes
  • Be especially vigilant with foods containing turmeric, garlic, ginger, and cranberry products if taking warfarin or other CYP2C9 substrates
  • Understand that consistent moderate intake is generally safer than sporadic high intake of these foods

Special Considerations

  • Genetic polymorphisms in CYP2C9 (e.g., CYP2C92, CYP2C93) can amplify food-drug interactions 2
  • Elderly patients and those with liver disease may be more susceptible to these interactions
  • Multiple concurrent CYP2C9 inhibitors (foods and/or medications) can have additive effects

By understanding these interactions and maintaining consistent dietary habits, patients can help minimize the risk of adverse effects related to CYP2C9 inhibition.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Chapter Title: Vegetable-Drug Interactions and the Cytochrome P450 Enzyme System

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Dietary effects on drug metabolism and transport.

Clinical pharmacokinetics, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.